Comerica Bank
APGE icon

Comerica Bank’s Apogee Therapeutics APGE Stock Holding History

Comerica Bank’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.71M Buy
35,872
+338
+1% +$21.3K 0.01% 964
2025
Q3 		$1.41M Buy
35,534
+6,065
+21% +$232K 0.01% 1357
2025
Q2 		$1.28M Buy
29,469
+14,109
+92% +$537K 0.01% 1381
2025
Q1 		$574K Sell
15,360
-5,180
-25% -$200K ﹤0.01% 1780
2024
Q4 		$930K Sell
20,540
-7,518
-27% -$383K ﹤0.01% 1589
2024
Q3 		$1.65M Buy
28,058
+27,952
+26,370% +$1.34M 0.01% 1247
2024
Q2 		$4.17K Sell
106
-6,470
-98% -$314K ﹤0.01% 3338
2024
Q1 		$437K Buy
6,576
+6,470
+6,104% +$282K ﹤0.01% 1939
2023
Q4 		$2.96K Hold
106
– – ﹤0.01% 3433
2023
Q3 		$2.26K Buy
+106
New +$2.33K ﹤0.01% 3547

Other funds holding APGE

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Comerica Bank's APGE Position: Q4 2025 in Review

Comerica Bank increased its Apogee Therapeutics (APGE) stake by 0.95% in Q4 2025, buying an estimated $21.3K and bringing the position to 35,872 shares worth $2.71M. The position accounts for 0.01% of the portfolio, ranked #964.

Comerica Bank first reported a position in APGE in Q3 2023 and has held it in 10 quarters since. 206 funds tracked by Wall St. Rank hold APGE as of Q4 2025.

  • Comerica Bank held 35,872 shares of Apogee Therapeutics worth $2.71M as of Q4 2025.
  • Comerica Bank bought 338 Apogee Therapeutics shares in Q4 2025, an estimated $21.3K.
  • Apogee Therapeutics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #964 holding.
  • Comerica Bank first reported a position in Apogee Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 206 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.